FedEx has announced the launch of FedEx Life Sciences, a “dedicated organization created to support the increasingly complex movement of pharmaceuticals, medical devices, biologics, clinical trials, and other critical healthcare shipments.”

Healthcare supply chains require specialized support, including “temperature-sensitive therapies and clinical trial materials to medical devices and patient-critical shipments.” FedEx Life Sciences introduces a dedicated healthcare team and advanced monitoring capabilities to their global network.

Brie Carere, FedEx’s executive vice president and chief customer officer, said that the new organization will bring together FedEx’s “global network, advanced monitoring, and specialized expertise to make supply chains smarter and more resilient.” It also builds on significant investments the company has already made in healthcare infrastructure and technology.

FedEx will also open six Life Sciences Centers globally, and new routes between Indianapolis and Dublin have “strengthened transatlantic connectivity between these two critical pharmaceutical manufacturing hubs, as the company continues to connect global pharmaceutical epicenters.”